We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AG icon
3476
First Majestic Silver
AG
$10.3B
$136K ﹤0.01%
23,006
-35,505
-61% -$197K
BLFS icon
3477
BioLife Solutions
BLFS
$1.82B
$136K ﹤0.01%
11,318
-201,892
-95% -$2.41M
HQI icon
3478
HireQuest
HQI
$245M
$135K ﹤0.01%
36,321
-6,435
-15% -$29.9K
ZEPP
3479
Zepp Health
ZEPP
$73.2M
$135K ﹤0.01%
3,442
-10,133
-75% -$398K
AAC
3480
DELISTED
AAC Holdings
AAC
$135K ﹤0.01%
96,496
-211,717
-69% -$850K
GLO
3481
Clough Global Opportunities Fund
GLO
$246M
$134K ﹤0.01%
16,300
+5,980
+58% +$56.7K
ARDS
3482
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$134K ﹤0.01%
12,112
-11,473
-49% -$131K
IO
3483
DELISTED
ION Geophysical Corporation
IO
$132K ﹤0.01%
+25,388
New +$258K
ETJ
3484
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$565M
$130K ﹤0.01%
+16,045
New +$147K
TOUR
3485
Tuniu
TOUR
$53.9M
$128K ﹤0.01%
2,635
-889
-25% -$54K
PLYM
3486
DELISTED
Plymouth Industrial REIT
PLYM
$127K ﹤0.01%
10,102
-15,011
-60% -$199K
CHI
3487
Calamos Convertible Opportunities and Income Fund
CHI
$1.03B
$126K ﹤0.01%
+14,200
New +$141K
IGR
3488
CBRE Global Real Estate Income Fund
IGR
$704M
$126K ﹤0.01%
20,458
+9,543
+87% +$64.1K
CCEC
3489
Capital Clean Energy Carriers
CCEC
$1.38B
$126K ﹤0.01%
8,582
+6,814
+385% +$123K
CRK icon
3490
Comstock Resources
CRK
$4.19B
$123K ﹤0.01%
27,096
+15,626
+136% +$115K
DRYS
3491
DELISTED
DryShips Inc. Common Stock
DRYS
$123K ﹤0.01%
+21,764
New +$120K
CRIS icon
3492
Curis
CRIS
$3.83M
$122K ﹤0.01%
444
-158
-26% -$86.4K
JQC icon
3493
Nuveen Credit Strategies Income Fund
JQC
$704M
$120K ﹤0.01%
+16,180
New +$124K
CSBR icon
3494
Champions Oncology
CSBR
$69.1M
$119K ﹤0.01%
15,196
-10,173
-40% -$117K
SELF
3495
Global Self Storage
SELF
$64.8M
$118K ﹤0.01%
30,083
-22,716
-43% -$91.1K
ARA
3496
DELISTED
American Renal Associates Holdings, Inc
ARA
$118K ﹤0.01%
10,267
-99,636
-91% -$1.7M
STKL
3497
DELISTED
SunOpta
STKL
$117K ﹤0.01%
+30,140
New +$172K
UCTT
3498
Ultra Clean Holdings
UCTT
$3.3B
$117K ﹤0.01%
+13,799
New +$135K
LGTY
3499
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$117K ﹤0.01%
+11,200
New +$124K
BOE icon
3500
BlackRock Enhanced Global Dividend Trust
BOE
$690M
$115K ﹤0.01%
12,261
-37,474
-75% -$379K

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.